Form 13-F position report

ACASTI PHARMA INC

Reported by CITADEL ADVISORS LLC

ACSTXXXX CUSIP 00430K402 Manager CIK 0001423053

Reported 0 shares, down 110,889 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 9 Through Q3 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for ACASTI PHARMA INC held by CITADEL ADVISORS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2021 Reduced 0 -110,889 (-100.0%) 0 $0 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

26 managers reported ACASTI PHARMA INC for Q3 2021.

Managers reporting ACASTI PHARMA INC in Q3 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
EDMOND DE ROTHSCHILD HOLDING S A Reduced 12,500 -87,500 < 0.01% $25,000 3 qtrs
Sterling Investment Advisors Ltd Reduced 5,000 -35,000 < 0.01% $10,000 9 qtrs
COMMONWEALTH EQUITY SERVICES LLC Reduced 0 -15,700 0 $0 2 qtrs
TORONTO DOMINION BANK Reduced 0 -473 0 $0 4 qtrs
Squarepoint Ops LLC Reduced 0 -94,500 0 $0 3 qtrs
Sargent Bickham Lagudis LLC Reduced 0 -40 0 $0 4 qtrs
CITADEL ADVISORS LLC This report Reduced 0 -110,889 0 $0 9 qtrs
ROYAL BANK OF CANADA Reduced 0 -25 0 $0 21 qtrs
AdvisorNet Financial Inc Reduced 0 -300 0 $0 7 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 0 -146,784 0 $0 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2021
Filed
November 15, 2021
Filing type
13F-HR
Position type
CL A NEW

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.